event-trade登录编辑
BenzingaDoubao · 实盘不做把握 9/10不做原因:无增量信息
北京时间·🕒 发布 07:15:16·⟳ 抓取 07:16:55 +1m39s·⚡ 决策 10-13 11:14:38 +3h57m·14.5 天前

Benzinga自动稿回顾Roivant近五年涨幅,未含任何新增基本面信息

这是Benzinga自动生成的历史收益回顾稿,全部数据均为公开存量信息,没有任何会改变未来盈利预期或供需的新事实,无交易edge,直接不做。

📄 原文Benzinga↗ 原文
Here’s How Much You Would Have Made Owning Roivant Sciences Stock In The Last 5 Years
Roivant Sciences (NASDAQ:ROIV) has outperformed the market over the past 5 years by 30.08% on an annualized basis produ…
不做 Roivant Sciences(ROIV.US)
Benzinga自动稿仅回顾五年历史涨幅与复利,无新增基本面、订单、业绩或指引信息,不构成事件驱动edge;历史收益不能外推,不做多也不做空。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)

研究档案

结论摘要

Benzinga自动化稿仅复算ROIV五年历史回报与复利效应,无新增基本面催化;历史涨幅不代表未来,不构成可交易事件,AVOID。

🔎 新鲜度:最早出现 2026-10-12 · 扩散 low · price-in 风险 low ↗

主要风险

  • 若读者将历史高回报外推为未来收益,可能在无新催化下追高,属行为风险而非事件edge。

先例如何影响了这次决策

对本次决策的影响:未改变结论,直接确认NO_INCREMENTAL_FACT,不做

方向:无可比先例:自动化历史回报稿不是催化事件,先例统计不适用

涨幅量级:无增量事件,无需也无法用先例校准幅度

形态:无

原文全文

展开原文 · 897 字
Roivant Sciences (NASDAQ:ROIV) has outperformed the market over the past 5 years by 30.08% on an annualized basis producing an average annual return of 41.86%. Currently, Roivant Sciences has a market capitalization of $25.60 billion.
Buying $1000 In ROIV: If an investor had bought $1000 of ROIV stock 5 years ago, it would be worth $5,661.21 today based on a price of $34.59 for ROIV at the time of writing.
Roivant Sciences’s Performance Over Last 5 Years
Finally -- what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.

决策记录链 · 只追加

每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。

  1. 6c7e91d22f · 2026-10-13 11:14 · doubao / doubao-seed-evolving-latest-version · 策略包 2226518bfdee当前